I really like your other assessments with other posts (not in MDR). So respect. What is it that you are seeing though that I am missing here? MDR's business model to me seems broke? Poor organic revenue growth and a "hope" of growth from international expansion. We all know how hard and costly that is for any Australian company (very few ever succeed). Good runway seems the only positive - that is, access to cash. Otherwise, as a small cap, the organic growth numbers seem mind numbingly bad IMO?
Ann: MedAdvisor Quarterly Report & Appendix 4C, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 27.5¢ | $248.7K | 869.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24636 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 13888 | 2 |
View Market Depth
| Last trade - 15.28pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
